Emerald Bioventures, established in 2021 and based in New York, is a venture capital firm focused on the incubation and development of companies in the life sciences, biotechnology, and health technology sectors. The firm aims to identify and support innovative ventures in medtech and life sciences, providing the necessary resources and expertise to foster growth and advancement in these critical fields. Through its strategic investments, Emerald Bioventures is committed to driving innovation and improving health outcomes by nurturing startups that have the potential to make a significant impact in the healthcare landscape.
Aikium is a biotechnology company that specializes in developing novel protein therapeutics for neuro-inflammation and oncology. It combines advancements in synthetic biology and deep learning to create unique, non-antibody scaffold proteins that specifically target and bind to disordered regions of proteins, offering innovative solutions for clients to effectively address disordered proteins.
Bask Health
Pre Seed Round in 2022
Bask Health is an e-commerce platform focused on telehealth services, enabling the launch and scaling of direct-to-consumer telehealth businesses. The company provides a comprehensive suite of services that includes electronic medical records, payment processing, pharmacy fulfillment, website building, and patient management systems. By integrating these resources, Bask Health simplifies the process for merchants and businesses to establish and operate their e-prescribing services, facilitating seamless connections and enhancing the overall patient experience.
eGlint
Seed Round in 2021
eGlint is a developer of a miniature biosensing device that utilizes a small volume of blood to detect multiple biomarkers. This innovative technology aims to enhance the efficiency of biomarker identification in the medical field. By offering a device capable of analyzing various biomarkers from a minimal blood sample, eGlint seeks to improve diagnostic processes and patient care within the healthcare industry.
Health Outlook
Pre Seed Round in 2021
Health Outlook is a healthcare startup focused on enhancing predictions of longevity and health events through advanced analytics. The company employs proprietary algorithms that combine traditional mortality risk factors with modern proteomic markers, allowing for more accurate assessments. By utilizing progressive statistical techniques, Health Outlook aims to assist clients in improving life expectancy outcomes. The company is also exploring opportunities in the financial services and health systems markets, launching initiatives that capitalize on its predictive capabilities. Overall, Health Outlook seeks to advance the understanding of health risks and longevity, providing valuable insights for both individuals and organizations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.